Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Wiener Klinische Wochenschrift|April 15, 2025
Markers for the angiogenic potential of fat graftsMaryana Teufelsbauer, Sandra Stickler, Marie-Therese Eggerstorfer, et al.Anti-Cancer Drugs|December 20, 2021
Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pairBarbara Rath, Adelina Plangger, Dagmar Krenbek, et al.Cancer Biology & Therapy|March 9, 2011
The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancerKatrin Wlcek, Martin Svoboda, Juliane Riha, et al.Investigational New Drugs|October 1, 2021
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung CancerAdelina Plangger, Barbara Rath, Maximilian Hochmair, et al.Anticancer Research|February 29, 2024
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell LinesClemens Lang, Sandra Stickler, Barbara Rath, et al.Anticancer Research|December 31, 2021
MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung CancerBettina Savarese-Brenner, Marlene Heugl, Barbara Rath, et al.Scientific Reports|January 22, 2025
Characterization of a pleomorphic rhabdomyosarcoma cell lineSandra Stickler, Clemens Lang, Maximilian Rieche, et al.Cancers|January 24, 2019
Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell LinesBarbara Rath, Lukas Klameth, Adelina Plangger, et al.Journal of Drug Delivery|March 12, 2013
The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumorsLena Secky, Martin Svoboda, Lukas Klameth, et al.Exploration of Targeted Anti-Tumor Therapy|May 19, 2023
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulationBarbara Rath, Adelina Plangger, Lukas Klameth, et al.Pageof 10